Zhiqiang Lin, Ph.D., has been promoted to associate professor of biomedical research and translational medicine at MMRI, recognizing his significant contributions since joining the organization in 2018. Lin has been instrumental in advancing cardiovascular research as a key faculty member at MMRI.

Lin earned his Ph.D. from Peking University in 2008, followed by postdoctoral research at Boston Children’s Hospital of Harvard Medical School under the tutelage of Dr. William T. Pu. In 2013, Dr. Lin was promoted to instructor at Harvard Medical School before being recruited by MMRI as assistant professor and principal investigator in 2018.

 

“It’s a tremendous honor to work and be recognized at MMRI,” said Dr. Lin. “I am energized and committed to advancing cardiac medicine and look forward to continuing impactful research that enhances human health.”

 

Lin’s area of investigation is focused on heart development and disease, with an emphasis on cardiomyocyte regeneration, metabolism and immune responses in the heart. Among his many accomplishments is his groundbreaking work on the role of the SARS-CoV Spike protein in COVID-19-related heart injury, alongside a series of publications and a patent on cardiac repair.

“Dr. Lin’s promotion underscores MMRI’s growing reputation as a leader in cardiovascular and biomedical research,” said Maria Kontaridis, Ph.D., executive director at MMRI. “We are proud of his achievements and excited for the continued success of his lab’s innovative work.”

 

To learn more about Dr. Lin’s laboratory, visit mmri.edu.

PLATINUM INVESTORS